Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:22PM EDT. Market open.
| Previous close | 87.75 |
| Open | 87.88 |
| Bid | 88.38 x 1100 |
| Ask | 88.42 x 800 |
| Day's range | 87.72 - 89.17 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 4,005,437 |
| Market cap | 53.268B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 38.48 |
| EPS (TTM) | 2.30 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 94.52 |
ZacksRising Demand Likely to Aid GE HealthCare's (GEHC) Q1 Earnings
GE HealthCare's (GEHC) first-quarter results are expected to report strong organic revenue growth, banking on balanced segmental performance driven by consistent NPIs and growing customer demand.
ZacksOngoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
ZacksDexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
© 2024 Yahoo. All rights reserved.